Relay Therapeutics (RLAY)

• Market cap: $1.81B
• 1 day: -2.22%
• 5 days: -1.27%
• 1 month: 10.59%
• 3 months: 19.46%
• 6 months: 145.28%
• Year to date: 23.84%
• 1 year: 188.6%
• 5 years: -74.84%
• 10 years: -71.1%
• Sector: Healthcare
• Industry: Biotechnology

About: Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Employees: 192